Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study.

Rebecca Landy, Gregory Haber,Barry I Graubard,Nicole G Campos,Stephen Sy,Jane J Kim,Emily A Burger,Li C Cheung,Hormuzd A Katki,Maura L Gillison,Anil K Chaturvedi

Journal of the National Cancer Institute（2023）

引用 2|浏览25

暂无评分

摘要

Most causal oral HPV16 infections in US men are acquired by age 26 years, underscoring limited benefit from vaccination of men aged 27-45 years for prevention of HPV16-positive oropharyngeal cancers.

查看译文

关键词

male human papillomavirus vaccination,oropharyngeal cancer prevention,upper age limits,microsimulation-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要